Talazoparib

Talazoparib is an advanced medication used to treat specific forms of cancer, mainly breast and ovarian cancers, in people with genetic mutations called BRCA mutations. It works by blocking a protein called PARP, which cancer cells rely on to repair their DNA. When PARP is inhibited, cancer cells with BRCA mutations cannot fix their DNA damage, leading to their death, while normal cells are less affected. This targeted approach helps to effectively weaken cancer cells while minimizing damage to healthy tissue, making Talazoparib a valuable option in personalized cancer therapy.